Table 2 Procedural characteristics and outcomes

Duration (min)

70 (60–80)

65 (60–75)

72 (66–81)

 < 0.005

TAVI in TAVI

0

0

0

1

TAVI in SAVR, n, (%)

13 (6.5)

5 (5)

8 (8)

0.30

THV size (mm)

26 (23–26)

26 (23–26)

26 (23–29)

0.43

Post mPG^* (mmHg)

8 (5–10)

6 (4–8)

6 (4–8)

0.97

Post pPG^* (mmHg)

15 (10–18)

12 (9–16)

12 (8–16)

0.58

Post AVA^* (cm²)

2 (1.7–2.3)

2 (1.8–2.3)

2.1 (1.8–2.5)

0.94

Tamponade (detected in cath lab), n (%)

6 (3)

3 (3)

3 (3)

1

Tamponade (delayed detection), n (%)

2 (1)

1 (1)

1 (1)

1

LoS (days)

1 (1–1)

1 (1–1)

1 (1–1)

0.49

Urgent ECHO

(after exit from cath lab), n (%)

4 (2)

2 (2)

2 (2)

1

PVL

 No, n (%)

126 (63)

66 (66)

60 (60)

 Trivial, n (%)

58 (29)

29 (29)

29 (29)

 Mild, n (%)

16 (8)

5 (5)

11 (11)

0.28

30-day readmissions, n (%)

16 (8)

7 (7)

9 (9)

0.6

In-hospital mortality, n (%)

2 (1)

1 (1)

1 (1)

1

30-day mortality, n (%)

2 (1)

1 (1)

1 (1)

1

30-day CVA, n (%)

1 (0.5)

0

1 (1)

0.32

30-day cardiac readmissions, n (%)

3 (1.5)

2 (2)

1 (1)

0.56

30-day new PPM, n (%)

9 (4.5)

5 (5)

4 (4)

0.73